Go Pro
OTCMKTS:SKVI

Skinvisible (SKVI) Stock Price, News & Analysis

$0.20 +0.00 (+0.55%)
As of 03:58 PM Eastern

About Skinvisible Stock (OTCMKTS:SKVI)

Advanced

Key Stats

Today's Range
$0.20
▼
$0.20
50-Day Range
$0.18
▼
$0.43
52-Week Range
$0.14
▼
$0.90
Volume
570 shs
Average Volume
54 shs
Market Capitalization
$1.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Skinvisible, Inc. is a specialty healthcare and personal-care company focused on developing topical products and delivery technologies. Its principal technology, Invisicare, is a polymer-based delivery system designed to help keep active ingredients on the skin and improve the performance and usability of topical formulations.

The company has pursued applications for Invisicare in pharmaceutical, cosmetic, antimicrobial, wound-care and personal-care products. Its activities have included developing products internally and working with commercial partners to formulate, license or distribute topical treatments and skin-care products.

Skinvisible has historically operated from the United States and has been described as a development-stage company. Publicly available information about its current operations, product availability, geographic reach and leadership is limited, so the company’s present business status and management structure cannot be described reliably.

AI Generated. May Contain Errors.

Receive SKVI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Skinvisible and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SKVI Stock News Headlines

Skinvisible Inc.
Elon Musk’s Hushed FCC Filing. Dec 8th.
Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the largest markets in the world. James Altucher, who previously flagged Nvidia in 2008 and Bitcoin in 2013, says the filing could rival Tesla, SpaceX and xAI combined. Few investors know this filing exists, but that is expected to change quickly.tc pixel
Skinvisible Stock Price History
Skinvisible, Inc. (SKVI)
See More Headlines

SKVI Stock Analysis - Frequently Asked Questions

Skinvisible's stock was trading at $0.2306 at the beginning of the year. Since then, SKVI stock has decreased by 12.4% and is now trading at $0.2021.

Skinvisible Inc. (OTCMKTS:SKVI) announced its quarterly earnings data on Thursday, August, 13th. The company reported ($0.05) earnings per share (EPS) for the quarter.

Shares of SKVI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Skinvisible investors own include Angus Energy (ANGS), HEXO (HEXO), Liberty Silver (BHLL), Blue Dolphin Energy (BDCO), American Power Group (APGI), Advanced Oxygen Technologies (AOXY) and Aeolus Pharmaceuticals (AOLS).

Company Calendar

Last Earnings
8/13/2026
Today
9/28/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:SKVI
CIK
1085277
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.06 million
Net Margins
-5,150.00%
Pretax Margin
-5,160.00%
Return on Equity
N/A
Return on Assets
-817.55%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.01
Quick Ratio
0.01

Sales & Book Value

Annual Sales
$20 thousand
Price / Sales
54.57
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.90) per share
Price / Book
-0.11

Miscellaneous

Outstanding Shares
5,400,000
Free Float
2,540,000
Market Cap
$1.09 million
Optionable
Not Optionable
Beta
1.71
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:SKVI) was last updated on 9/28/2026 by MarketBeat.com Staff.
From Our Partners